Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dry AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01337414
What this trial is testing

Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Johns Hopkins University 324
Not applicableUnknownNCT03859245
What this trial is testing

Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention

Who this might be right for
Diabetic Retinopathy (DR)Age-related Macular Degeneration (AMD)Mid-peripheral Drusen Formation+1 more
Bristlecone Health, Inc. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05170048
What this trial is testing

Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD

Who this might be right for
Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
Evergreen Therapeutics, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00346060
What this trial is testing

Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.

Who this might be right for
Dry Age Related Macular Degeneration.
Radtke, Norman D., M.D. 10
Not applicableActive Not RecruitingNCT05797896
What this trial is testing

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyRetinal Disease+4 more
Complement Therapeutics 250
Large-scale testing (Phase 3)Study completedNCT04005352
What this trial is testing

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 734
Post-approval studies (Phase 4)Study completedNCT00751361
What this trial is testing

Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial

Who this might be right for
Dry Age Related Macular Degeneration
Apheresis Research Institute 52
Not applicableWithdrawnNCT02699216
What this trial is testing

BioCurrent Electrical Stimulation for the Treatment of Dry ARMD

Who this might be right for
Dry Macular Degeneration
DuBois Vision Clinic
Not applicableUnknownNCT00926861
What this trial is testing

Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD

Who this might be right for
Dry Age-related Macular DegenerationDetachment of the Posterior Hyaloid
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 320
Post-approval studies (Phase 4)Study completedNCT02161575
What this trial is testing

Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 103
Not applicableLooking for participantsNCT05465252
What this trial is testing

Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression

Who this might be right for
Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 24
Testing effectiveness (Phase 2)Looking for participantsNCT04339764
What this trial is testing

Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

Who this might be right for
Dry Age-Related Macular DegenerationGeographic Atrophy
National Eye Institute (NEI) 20
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Large-scale testing (Phase 3)UnknownNCT00466076
What this trial is testing

Copaxone in Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
Kaplan Medical Center 30
Not applicableNot Yet RecruitingNCT07433088
What this trial is testing

Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration as Clinical Endpoints

Who this might be right for
Dry AMDGeographic AtrophyHealhty
Streetlab 60
Not applicableActive Not RecruitingNCT07298291
What this trial is testing

Ocular Proteomics Testing In Chronic Atrophy

Who this might be right for
Age-Related (Dry) Macular Degeneration
ClinOmicsAI 50
Not applicableUnknownNCT03433885
What this trial is testing

Wenzhou Dry Age-related Macular Degeneration (AMD) Progression Study

Who this might be right for
Macular Pigment Optical Density
The Eye Hospital of Wenzhou Medical University 300
Not applicableNot Yet RecruitingNCT07700147
What this trial is testing

Evaluation of an Electric Stimulator for Medical Use by Personal (LRTPM1) for Visual Function in Early to Intermediate Dry Age-Related Macular Degeneration

Who this might be right for
Dry Age-Related Macular DegenerationAMD
Nu Eyne Co., Ltd. 40
Not applicableStudy completedNCT06860555
What this trial is testing

Hyperspectral Drusen Classification

Who this might be right for
Dry Age Related Macular Degeneration
Optina Diagnostics Inc. 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT02286089
What this trial is testing

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Hoffmann-La Roche 24
Next Page